Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Healthcare resource utilization and associated cost in patients with metastatic non-small cell lung cancer treated in the immunotherapy era.
Journal: The oncologist
Published: July 23, 2024
Real-world treatment patterns, biomarker testing, and clinical outcomes of metastatic non-small cell lung cancer patients in the immunotherapy era.
Journal: Frontiers in oncology
Published: June 03, 2024
Reply to "Metformin as a booster or obstacle of immunotherapy in patients with non-small cell lung cancer and diabetes mellitus".
Journal: Cancer
Published: November 21, 2023
Publicly Funded Cancer Care: Are Adjuvant Therapies Prioritized Over Treatment of Metastatic Cancer? The Israeli Experience.
Journal: JCO oncology practice
Published: November 15, 2023
Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting.
Journal: Breast cancer (Dove Medical Press)
Published: November 06, 2023
Time on Treatment and Survival Outcomes for Patients Treated With First-line Osimertinib vs. Other Tyrosine Kinase Inhibitors, for EGFR Mutation-positive Metastatic Non-small Cell Lung Cancer: Real-world Experience Data.
Journal: Anticancer research
Published: November 01, 2023
Real-world outcomes of patients with metastatic endocrine-responsive breast cancer receiving palbociclib-based combinations.
Journal: Future oncology (London, England)
Published: August 02, 2023
The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer.
Journal: Journal of pharmaceutical policy and practice
Published: December 08, 2022
Last Updated: 09/26/2026